Journal
DRUG DISCOVERIES AND THERAPEUTICS
Volume 7, Issue 3, Pages 109-115Publisher
INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
DOI: 10.5582/ddt.2013.v7.3.109
Keywords
Honokiol; magnolol; chemoprevention; UVB photocarcinogenesis; apoptosis
Categories
Funding
- Translational Cancer Research Center-South Dakota Governor's Office of Economic Developmen
Ask authors/readers for more resources
alpha-Santalol is active component of sandalwood oil and has been shown to have chemopreventive effects against chemically and UVB-induced skin cancer development in mice. alpha-Santalol is also shown to have skin permeation enhancing effects. Honokiol and magnolol isolated from Magnolia officinalis bark extract have also been shown to have chemopreventive effects against chemically and UVB-induced skin cancer in mice. This study was conducted to investigate the combination effects of alpha-santalol, honokiol and magnolol to study any additive/synergistic effects to lower the doses required for chemoprevention. Pretreatment of combinations of alpha-santalol with honokiol and magnolol significantly decreased tumor multiplicity upto 75% than control, alpha-santalol, honokiol and magnolol alone in SKH-1 mice. Combination of alpha-santalol with honokiol and magnolol also decreased cell viability, proliferation, and enhanced apotosis in comparision to alpha-santalol, honokiol and magnolol alone in Human epidrmoid carcinoma A431 cells. Overall, the results of present study indicated combinations of alpha-santalol with honokiol and magnolol could provide chemoprevention of skin cancer at lower doses than given alone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available